BioNxt Solutions Inc. (OTCMKTS:BNXTF) Sees Large Decline in Short Interest

by · The Cerbat Gem

BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) was the recipient of a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 4,400 shares, a drop of 91.7% from the November 30th total of 52,900 shares. Based on an average trading volume of 7,400 shares, the short-interest ratio is currently 0.6 days.

BioNxt Solutions Stock Performance

OTCMKTS BNXTF remained flat at $0.22 during trading hours on Thursday. The firm has a market cap of $24.95 million, a PE ratio of -5.50 and a beta of 0.84. The stock has a 50 day simple moving average of $0.20 and a two-hundred day simple moving average of $0.19. BioNxt Solutions has a 12-month low of $0.11 and a 12-month high of $0.57.

About BioNxt Solutions

(Get Free Report)

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.

Featured Stories